Aktiesnakken — September 2013
-
lorte aktie
-
rene 1. november. næste uge ved du også hvorfor
-
som jeg postede i GEN chatten, så er Novods peaksales i cll 1st line baseret på en global markdsandel under 5% (hvor US=1x, EU=1x og ROW=0,5x)
-
Med en BTD er det illusorisk at tro på at arzerra bliver et nicheprodukt med 5% markedsandel
-
ifht en total volumen på 377k er det egentlig ikke det helt store.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind